Randomised controlled trialindependent cross-checkabstract only checked★ key study I-INS-03 in-depth review

DCCT: better insulin treatment in type 1 diabetes

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Overview

Diabetes Control and Complications Trial Research Group; Nathan DM et al.. N Engl J Med 1993 · PMID 8366922 · DOI 10.1056/NEJM199309303291401

Intensive insulin cut the risk of eye damage by three-quarters and nerve damage by 60%, with more low-sugar episodes.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply

What did the researchers want to find out?: Does intensive insulin therapy reduce long-term complications in type 1 diabetes?
How was the study done?: Multicentre RCT (DCCT)
How many people, animals or samples were studied?: 1,441; Insulin-dependent (type 1) diabetes
What was actually found?: Large reductions in all microvascular complications.
How large was the observed effect?: Retinopathy -76%
What do the results mean in everyday life?: Insulin protects eyes, kidneys and nerves in type 1 diabetes.
What are the study's limitations?: Open-label; Selected young population
What does it say about Elawady's specific claim?: Contradicts C-INS-07, C-INS-09, C-DIAB-01; shows insulin efficacy and hypoglycaemia cost (C-INS-02 kernel).
Do the results apply to Germany and Europe?: North American; universally accepted.
What can explicitly not be concluded from this study?: Effects in type 2 diabetes directly.

Scientific in-depth review

1. Full reference

Authors: Diabetes Control and Complications Trial Research Group; Nathan DM et al.
Journal: N Engl J Med
Year: 1993
Identifier: PMID 8366922 DOI 10.1056/NEJM199309303291401
Verification: verified – PubMed efetch 2026-10-25 (this agent)
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: not stated in abstract

2. Research question

Does intensive insulin therapy reduce long-term complications in type 1 diabetes?

3. Study design and population

Study design: Randomised controlled trial – Multicentre RCT (DCCT)
Population: Insulin-dependent (type 1) diabetes
Country: USA and Canada
Period: Mean 6.5 years
Sample size: 1,441
Inclusion and exclusion criteria: As described in the abstract; details not available in abstract.

4. Methods and endpoints

Exposure / intervention: Intensive therapy (pump or >=3 injections, frequent monitoring)
Comparator: Conventional 1-2 daily injections
Endpoints: Retinopathy, nephropathy, neuropathy
Statistical methods: Adjusted mean risks

5. Actual results

Results: Retinopathy development -76% (62-85); progression -54% (39-66); proliferative/severe -47%; microalbuminuria -39%; albuminuria -54%; clinical neuropathy -60%. Severe hypoglycaemia 2-3-fold higher.
Absolute risks: not reported
Authors' conclusion: Intensive therapy delays onset and slows progression of retinopathy, nephropathy and neuropathy in IDDM.

6. Strengths

Landmark RCT
Objective endpoints

7. Weaknesses

Open-label
Selected young population

8. Risk of bias

Orienting tool: RoB 2
Type of assessment: simplified assessment (abstract only)
Full formal assessment: no
Overall risk of bias: low
Rationale: Graded retinopathy photographs.

9. Assessment of the statistical interpretation

Large, precise effects.

10. Relevance to the specific claim

Contradicts C-INS-07, C-INS-09, C-DIAB-01; shows insulin efficacy and hypoglycaemia cost (C-INS-02 kernel).

11. Independent contrary findings

12. Transferability to Germany and Europe

North American; universally accepted.

13. Overall methodological judgement

Definitive evidence that insulin-based glucose control prevents complications in type 1 diabetes.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	high
Risk of bias	low
Precision of results	high
Directness	direct
Reproducibility	replicated
Consistency with the overall evidence	consistent
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable

14. Open questions

None beyond those stated.

15. Linked fact checks

Injected insulin halts the Krebs cycle, blocks protein and DNA synthesis, starves the brain of glucose and causes seizures and blood clots. – Studies contradicting or limiting the claim
Large trials in type 2 diabetes showed that intensive glucose lowering towards normal HbA1c can be harmful: ACCORD was stopped after intensive therapy raised all-cause mortality by 22%, and severe hypoglycaemia was associated with roughly doubled mortality. – Studies contradicting or limiting the claim
There is no such thing as type 1 diabetes; 'type 1' is a state of high sugar seen mainly in athletes with high needs; type 1 patients do not develop complications; insulin before puberty is a catastrophe (short stature, thyroid problems, cysts). – Studies contradicting or limiting the claim
Insulin is not needed for glucose to enter cells (the HbA1c inside red blood cells proves it); insulin therefore does not treat diabetes but 'starves' cells, especially the brain, of sugar. – Studies contradicting or limiting the claim
People with diabetes can stop insulin and diabetes medication by following the Tayebat system ('zero medicine'), as shown by followers who stopped insulin and are 'perfectly fine'. – Studies contradicting or limiting the claim
Insulin and diabetes drugs pull glucose out of the blood and out of the cells, producing an internal 'famine'. – Studies contradicting or limiting the claim
High blood sugar is not a disease but the body's protective response that 'rescues' you; there is no such thing as diabetes ('drink sugar'); sugar intake has no upper limit; HbA1c is a lie. – Studies contradicting or limiting the claim
Diabetes can be cured by following the Tayebat system without medication, illustrated by a patient who stopped insulin after 30 years of insulin use. – Studies contradicting or limiting the claim